However, IL-34 knockdown enhanced the susceptibility of CRC cells to oxalipaltin-induced death, in line with the demonstration that IL-34, produced during chemotherapy, increases lung cancer cell survival [47]. This evidence concerns the gene IL34 and lung cancer.